enGene Therapeutics, Inc. (ENGN)
1.67
+0.02
(+1.21%)
USD |
NASDAQ |
Jun 09, 16:00
1.68
+0.01
(+0.60%)
After-Hours: 20:00
enGene Therapeutics SG&A Expense (Quarterly) : 8.93M for Jan. 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 22.03M |
| Medicus Pharma Ltd. | 4.296M |
| Xenon Pharmaceuticals, Inc. | 23.82M |
| Psyence Biomedical Ltd. | 0.2659M |
| Agenus, Inc. | 6.86M |